Market Dynamics of Blood Screening Market
Drivers
- Increasing Number of Blood Donations and Blood Donors
- Increasing Demand of Donated Blood
- Rising Prevalence of Infectious Diseases
- Growing Affordability and Adoption of NAT for Blood Screening
- Rising Awareness Regarding the Safety of Donated Blood
Restraints
- Capital Expenditure and Operating Costs of NAT
- Lack of Regulations Mandating the Use of NAT in Developing Countries
- Emergence of Alternative Technologies
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042
Opportunities
- Pathogen Reduction Technology
- Multiplex Tests
- Emerging Economies
The major players in this market include Grifols (Spain), Ortho Clinical Diagnostics, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Roche Diagnostics (Switzerland), Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), bioMérieux (France), and Siemens Healthineers (Germany), and Bio-Rad Laboratories, Inc. (U.S.).
The global blood screening market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Asia is expected to witness the highest CAGR during the forecast period, with the growth in this market centred at China, Japan, and India.
To Know More @ https://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html
